cvac

Vaccineexperimental

Clinical trial activity

3 trials · 17 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 2010 (NCT01068509)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • cvac

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02310971Phase 2Feb 1, 2015Immutep S.A.
NCT01521143Phase 2Jan 1, 2012Immutep S.A.
NCT01068509Phase 2Jul 1, 2010Austin Health, Duke University, Griffith University, Immutep S.A., Indiana University, Marin Cancer Care, Medical University of South Carolina, Morristown Memorial Hospital, New York Presbyterian Hospital, Peter MacCallum Cancer Centre, Scripps, Stanford University, University of Adelaide, University of California, San Francisco, University of Queensland, University of Rochester, University of Washington
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (17)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Immutep S.A.For profit3312010
Austin HealthAcademic/Hospital1012010
Duke UniversityAcademic/Hospital1012010
Griffith UniversityAcademic/Hospital1012010
Indiana UniversityAcademic/Hospital1012010
Marin Cancer CareAcademic/Hospital1012010
Medical University of South CarolinaAcademic/Hospital1012010
Morristown Memorial HospitalAcademic/Hospital1012010
New York Presbyterian HospitalAcademic/Hospital1012010
Peter MacCallum Cancer CentreAcademic/Hospital1012010
ScrippsAcademic/Hospital1012010
Stanford UniversityAcademic/Hospital1012010
University of AdelaideAcademic/Hospital1012010
University of California, San FranciscoAcademic/Hospital1012010
University of QueenslandAcademic/Hospital1012010
University of RochesterAcademic/Hospital1012010
University of WashingtonAcademic/Hospital1012010
17 organizations
Page 1 / 1